-
How A Drug To Treat Dermal Kala-azar Is Affecting Patients’...
27 Mar 2024 06:31 GMT
… 2024, but a drug used to treat the skin manifestation of … of a multi-centre trial led by Drugs for Neglected Diseases … of Bihar who developed severe eye complications during treatment. One of … The scientific name is Visceral Leishmaniasis. It is caused by a …
-
Polymeric Nanohydrogel in Topical Drug Delivery System
15 Mar 2024 09:12 GMT
… For the treatment of diseases, nanomedicine, pharmaceuticals, and … of achieving adequate medication absorption via the … treating dermatological conditions. Polymers are pivotal in developing these drug … dressing in cutaneous leishmaniasis. Biointerface Res Appl …
-
Can AI help scientists develop drugs faster? Northeastern Institute for Experiential AI explores how the emerging technology is reshaping pharmaceutical development
29 Feb 2024 18:00 GMT
… AI is being used for drug development. Photo by Alyssa Stone … being used to develop new drugs and medical treatments. Photos by … who are working on drugs to treat neglected tropical diseases, as … Chugs disease), malaria and Leishmaniasis. One of our goals …
-
Studies to Evaluate Blood Safety: Risk of Transmission of Parasites such as Trypanosoma cruzi through Blood Transfusion
26 Mar 2024 23:43 GMT
… could be exploited for drug and vaccine development, or for parasite … in blood to assess treatment efficacy and cure in … , prospective, phase-2 clinical trial in the Plurinational State of … in aged mice against visceral leishmaniasis.
Bhattacharya P, Dey R, …
-
Advanced Technology for Reducing the Risk of Transmission by Transfusion
26 Mar 2024 23:42 GMT
… protozoan parasites, having chaired FDA committees for product license review … significant projects, including 1) developing a Leishmania donovani genomic microarray … antimonial treatment in non-human primate model of cutaneous leishmaniasis.
Thacker …
-
Iran aims to produce world’s first vaccine for leishmaniasis
28 Feb 2024 12:00 GMT
… skin sores, and visceral leishmaniasis, which affects several internal … a vaccine for the treatment of Leishmaniasis, he said.
Sarvari … extensive efforts are underway to develop the vaccine. “The … and obtain the Food and Drug Organization approval, we will …
-
Perceived Social Stigma of Cutaneous Leishmaniasis in Hubuna, Saudi Arabia
28 Feb 2024 09:00 GMT
… area reported success in treating many of these cases … as there are no drugs or vaccines to prevent … highlight the importance of developing interventions to urgently address … Epidemiology, pathology and treatment of cutaneous leishmaniasis in Taif region of …
-
Zydus Lifesciences bags WHO prequalification nod for Miltefosine formulation, API to treat Leishmaniasis
26 Feb 2024 23:07 GMT
… and formulation of the key drug to treat Leishmaniasis, ‘Miltefosine’. With this, Miltefosine … Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. The … in the production of generic drugs. Cadila was founded in 1952 …
-
Nanoparticles containing natural substance treat visceral leishmaniasis with scant side effects
20 Feb 2024 18:16 GMT
… WHO).
The technique developed by the researchers … highly effective in treating the disease … medication at home, as well as versions for topical treatment of cutaneous leishmaniasis … in the Treatment of Experimental Visceral Leishmaniasis, Pharmaceuticals (2023 …
-
Five school children contract cutaneous leishmaniasis in Tiznit
14 Feb 2024 12:44 GMT
… leishmaniasis is a skin disease that causes the development … the World Health Organization, leishmaniasis usually affects poor populations … the confirmed cases of leishmaniasis have reached five … cases, including offering treatment protocols to the affected …